Kaczmarek, F.; Marcinkowska-Gapińska, A.; Bartkowiak-Wieczorek, J.; Nowak, M.; Kmiecik, M.; Brzezińska, K.; Dotka, M.; Brosz, P.; Firlej, W.; Wojtyła-Buciora, P.
Blood-Based Biomarkers as Predictive and Prognostic Factors in Immunotherapy-Treated Patients with Solid Tumors—Currents and Perspectives. Cancers 2025, 17, 2001.
https://doi.org/10.3390/cancers17122001
AMA Style
Kaczmarek F, Marcinkowska-Gapińska A, Bartkowiak-Wieczorek J, Nowak M, Kmiecik M, Brzezińska K, Dotka M, Brosz P, Firlej W, Wojtyła-Buciora P.
Blood-Based Biomarkers as Predictive and Prognostic Factors in Immunotherapy-Treated Patients with Solid Tumors—Currents and Perspectives. Cancers. 2025; 17(12):2001.
https://doi.org/10.3390/cancers17122001
Chicago/Turabian Style
Kaczmarek, Franciszek, Anna Marcinkowska-Gapińska, Joanna Bartkowiak-Wieczorek, Michał Nowak, Michał Kmiecik, Kinga Brzezińska, Mariusz Dotka, Paweł Brosz, Wojciech Firlej, and Paulina Wojtyła-Buciora.
2025. "Blood-Based Biomarkers as Predictive and Prognostic Factors in Immunotherapy-Treated Patients with Solid Tumors—Currents and Perspectives" Cancers 17, no. 12: 2001.
https://doi.org/10.3390/cancers17122001
APA Style
Kaczmarek, F., Marcinkowska-Gapińska, A., Bartkowiak-Wieczorek, J., Nowak, M., Kmiecik, M., Brzezińska, K., Dotka, M., Brosz, P., Firlej, W., & Wojtyła-Buciora, P.
(2025). Blood-Based Biomarkers as Predictive and Prognostic Factors in Immunotherapy-Treated Patients with Solid Tumors—Currents and Perspectives. Cancers, 17(12), 2001.
https://doi.org/10.3390/cancers17122001